2.4(top 20%)
impact factor
23.4K(top 1%)
papers
244.4K(top 2%)
citations
152(top 2%)
h-index
2.5(top 20%)
extended IF
24.8K
all documents
261.3K
doc citations
212(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trialsLung Cancer1996741
2Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumabLung Cancer2017677
3Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrumentLung Cancer1995670
4Metastatic sites and survival in lung cancerLung Cancer2014639
5Carcinoembryonic antigen (CEA) as tumor marker in lung cancerLung Cancer2012586
6Tobacco smoking and cancer: a brief review of recent epidemiological evidenceLung Cancer2004567
7EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291Lung Cancer2015462
8Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancerLung Cancer2005449
9Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancerLung Cancer1998438
10Complete resection in lung cancer surgery: proposed definitionLung Cancer2005428
11Effect of cigarette smoking on major histological types of lung cancer: a meta-analysisLung Cancer2001419
12Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerLung Cancer2017413
13Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancerLung Cancer2002402
14Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyLung Cancer2004402
15Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancersLung Cancer2015393
16Chemotherapy, chemoresistance and the changing treatment landscape for NSCLCLung Cancer2011389
17Radiomics and radiogenomics in lung cancer: A review for the clinicianLung Cancer2018378
18Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trialLung Cancer1999370
19An electronic nose in the discrimination of patients with non-small cell lung cancer and COPDLung Cancer2009361
20Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?Lung Cancer2002341
21The relationship between COPD and lung cancerLung Cancer2015335
22Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumabLung Cancer2018329
23A randomized trial of systematic nodal dissection in resectable non-small cell lung cancerLung Cancer2002325
24Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosisLung Cancer2006323
25Nodule management protocol of the NELSON randomised lung cancer screening trialLung Cancer2006316
26Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer1999315
27Angiogenesis in non-small cell lung cancer: The prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and bloodLung Cancer2006315
28International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in womenLung Cancer2014315
29Establishment and identification of small cell lung cancer cell lines having classic and variant featuresLung Cancer1986314
30Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutationLung Cancer2012310
31Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT imagesLung Cancer2004309
32Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distressLung Cancer2007307
33Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trialLung Cancer2006305
34Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerLung Cancer2010305
35Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?Lung Cancer2004301
36MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivoLung Cancer2009299
37B7-H3 and B7-H4 expression in non-small-cell lung cancerLung Cancer2006296
38Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasesLung Cancer1996294
39Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lungLung Cancer2003294
40A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)Lung Cancer2000293
41KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studiesLung Cancer2010292
42Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final reportLung Cancer2004288
43The role of radiotherapy in treatment of stage I non-small cell lung cancerLung Cancer2003285
44An investigation on electronic nose diagnosis of lung cancerLung Cancer2010281
45Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancerLung Cancer2005279
46Genetic alterations defining NSCLC subtypes and their therapeutic implicationsLung Cancer2013279
47Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry studyLung Cancer2005277
48Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trialLung Cancer2010271
49Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literatureLung Cancer2013269
50PIK3CA mutation status in Japanese lung cancer patientsLung Cancer2006267